Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Minerva Neurosciences Inc. buy geldnutzer

Start price
€2.35
11.06.21 / 50%
Target price
€2.90
11.06.22
Performance (%)
-6.05%
Price
€2.53
10.06.21
Summary
This prediction is currently active. With a performance of -6.05%, the BUY prediction by geldnutzer is trending in the wrong direction. This prediction currently runs until 11.06.22. The prediction end date can be changed by geldnutzer at any time. geldnutzer has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Minerva Neurosciences Inc. - - - -
S&P 500 -2.220% - - -

According to geldnutzer what are the pros and cons of Minerva Neurosciences Inc. for the foreseeable future?

Pros
Standard Investments for future growth
Future proof or reliable business model
Cons
Revenue decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
negative Cash Flow expected
Bad rating
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Bad culture
Little innovation
Growths slower than the competition
high free float
Below average Management
Few uniques
Dependend from some customers or products
Sustainability is little important
Higher risks for its business
Below average Marketposition
Significant cyclical dependencies
Little known brand
EBIT decline/stagnation expected
Probably not worthwhile Investment

Comments by geldnutzer for this prediction

In the thread Minerva Neurosciences Inc. diskutieren
Prediction Buy
Perf. (%) -6.05%
Target price 2.900
Change
Ends at 11.06.22

Buy mit Kursziel 2,9

Stopped prediction by geldnutzer for Minerva Neurosciences Inc.

Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€1.91
06.05.21
€2.30
06.05.22
23.09%
11.06.21

Revenue decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
buy
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€2.92
20.02.21
€3.30
20.02.22
-34.73%
06.05.21

Revenue decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€2.08
22.12.20
€1.80
22.12.21
40.38%
20.02.21

Revenue decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
buy
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€2.90
13.10.20
€2.40
04.11.21
-28.28%
22.12.20

Revenue decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€2.82
15.08.20
€2.00
13.10.20
2.84%
13.10.20

Revenue decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
buy
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€3.14
03.08.20
€4.00
15.08.20
-10.19%
15.08.20

Revenue decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€3.06
25.07.20
€2.00
03.08.20
2.61%
03.08.20

Revenue decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected